·

Mexico Medical Prosthetics Export Market -- HS Code 9021 Trade Data & Price Trend (Jan 2025)

Mexico's Medical Prosthetics (HS Code 9021) Export hit $450M in Jan 2025, with 90.4% to U.S. and 37% orthopaedic share, per yTrade data.

Mexico Medical Prosthetics Export (HS 9021) Key Takeaways

Mexico's Medical Prosthetics Export under HS Code 9021 in January 2025 reveals a high-volume, value-differentiated market, dominated by orthopaedic appliances (37% of exports) alongside premium-priced hearing aids and specialized devices. The $450.07 million opening month signals strong demand, supported by streamlined trade regulations. Buyer concentration is stark, with 65.4% of export value tied to high-frequency clients like BREG, INC, creating both stability and dependency risk. The U.S. absorbs 90.4% of exports, reflecting deep OEM integration, while Canada and Europe offer higher-margin niche opportunities. This analysis is based on cleanly processed January 2025 Customs data from the yTrade database.

Mexico Medical Prosthetics Export (HS 9021) Background

What is HS Code 9021?

HS Code 9021 covers orthopedic appliances, splints, hearing aids, and medical prosthetics. These products are critical for rehabilitation and mobility support, driving steady global demand from healthcare providers and aging populations. The sector benefits from technological advancements and increasing accessibility to medical care worldwide.

Current Context and Strategic Position

Mexico's foreign trade rules for 2025, including updates to temporary import provisions under Article 108 of the Customs Law, may impact the logistics and cost structure of medical prosthetics exports [International Trade Compliance Update]. Mexico's strategic position as a manufacturing hub and its proximity to the U.S. market make it a key player in the HS Code 9021 trade flow. Monitoring regulatory changes and supply chain adaptability will be essential for maintaining competitiveness in Mexico's medical prosthetics export sector.

Mexico Medical Prosthetics Export (HS 9021) Price Trend

Key Observations

Mexico's export of medical prosthetics under HS code 9021 reached a value of $450.07 million in January 2025, marking a solid opening for the Mexico Medical Prosthetics Export trend this year.

Price and Volume Dynamics

The January performance likely benefits from updated foreign trade regulations that streamlined customs processes for imported manufacturing equipment, as noted by [International Trade Compliance Update], potentially boosting production efficiency. This hs code 9021 value trend indicates a positive shift, supported by steady global healthcare demand and Mexico's expanding medical device sector.

Mexico Medical Prosthetics Export (HS 9021) HS Code Breakdown

Product Specialization and Concentration

In January 2025, Mexico's export under HS Code 9021 is dominated by orthopaedic or fracture appliances, specifically from sub-code 90211006, which accounts for approximately 37% of the total quantity exported. According to yTrade data, this product shows a unit price of around 52 USD per unit, indicating a focus on high-volume, lower-priced items. A significant anomaly is present in artificial parts of the body, with unit prices exceeding 1100 USD, which is isolated from the main analysis due to its extreme value disparity.

Value-Chain Structure and Grade Analysis

The remaining exports can be grouped into three categories: hearing aids with unit prices near 200 USD, orthopaedic appliances at about 53 USD, and other medical appliances like those for body defects at around 366 USD. This variety in unit prices and product types, as seen in HS Code 9021 trade data, points to a market of differentiated manufactured goods rather than fungible commodities, with clear distinctions in value-add stages from basic supports to advanced devices.

Strategic Implication and Pricing Power

Exporters under Mexico HS Code 9021 Export have stronger pricing power in high-value segments such as hearing aids and specialized appliances, where unit prices are higher. Strategic focus should prioritize innovation and quality control for these premium products to maintain competitiveness, while the high-volume orthopaedic segment may require efficiency gains to sustain margins in a competitive market.

Table: Mexico HS Code 9021) Breakdown Details (Source: yTrade)

HS CodeProduct DescriptionValueFrequencyQuantityWeight
902140**Hearing aids (excluding parts and accessories)91.54M5.24K459.08K2.09M
902140****Hearing aids (excluding parts and accessories)90.55M5.13K451.67K2.07M
902110**Orthopaedic or fracture appliances86.65M15.76K1.66M1.05B
9021******************************************

Check Detailed HS Code 9021 Breakdown

Mexico Medical Prosthetics Export (HS 9021) Destination Countries

Geographic Concentration and Dominant Role

The United States is the dominant destination for Mexico's Medical Prosthetics exports in January 2025, taking 90.40% of the total value. This share is slightly lower than its 99.45% weight share, suggesting shipments to the US carry a marginally lower average unit price. This points to a trade flow centered on bulk OEM (Original Equipment Manufacturer) contracts or high-volume component sourcing, rather than premium finished goods. The US also accounts for 83.52% of all shipment frequencies, confirming a deeply integrated, high-frequency supply chain.

Destination Countries Clusters and Underlying Causes

The remaining partners form two clear clusters. The first is a High-Yield Cluster, including Canada (2.40% value, 0.45% quantity), Switzerland (2.27% value, 1.17% quantity), Ireland (1.86% value, 0.06% quantity), and the Netherlands (1.27% value, 0.13% quantity). Their value shares significantly outpace their quantity shares, indicating demand for higher-value, specialized, or finished prosthetic devices. The second is a smaller Transactional Cluster with Germany, Australia, and Brazil. They show minimal volume but consistent, smaller-value shipments, typical of niche market orders or aftermarket part distribution.

Forward Strategy and Supply Chain Implications

Mexico's export strategy for Medical Prosthetics should continue to prioritize its deep OEM integration with the US market, optimizing logistics for high-volume, just-in-time delivery. To capture higher margins, efforts can be increased to serve the premium niche markets in the High-Yield Cluster, particularly in Canada and Western Europe. The minimal presence of other volume-driven partners suggests the current model is effective for leveraging proximity to a major manufacturing hub, and no major logistical shifts are immediately indicated by the January 2025 Mexico Medical Prosthetics export data for HS Code 9021.

Table: Mexico Medical Prosthetics (HS 9021) Top Destination Countries (Source: yTrade)

CountryValueQuantityFrequencyWeight
UNITED STATES406.86M4.35M39.76K2.18B
CANADA10.80M20.10K131.00389.41K
SWITZERLAND10.20M52.63K5.30K4.60M
IRELAND8.38M2.55K1.32K3.00M
NETHERLANDS5.73M5.98K348.00403.46K
POLAND************************

Get Complete Destination Countries Profile

Mexico Medical Prosthetics (HS 9021) Buyers Analysis

Buyer Market Concentration and Dominance

In January 2025, the Mexico Medical Prosthetics Export market shows strong concentration among a few key buyers. According to yTrade data, high-value and high-frequency buyers dominate, accounting for 65.40% of the total export value. This group also handles 90.78% of all transactions, making them the core of hs code 9021 trade data. The typical trade for Mexico Medical Prosthetics Export involves regular, high-volume shipments to these top clients.

Strategic Buyer Clusters and Trade Role

The other three segments of buyers play smaller roles: high-value but low-frequency buyers contribute 32.01% of value with infrequent large orders, while low-value groups add minimal value. The dominant high-value, high-frequency buyers, represented by companies like BREG, INC and BORGATTA SL, indicate a direct-to-factory or end-user market for Medical Prosthetics. The profile of HS code 9021 buyers suggests that most sales go directly to manufacturers or specialized medical firms, not through intermediaries.

Sales Strategy and Vulnerability

For exporters in Mexico, the strategy should prioritize nurturing relationships with high-value, high-frequency buyers to ensure stable revenue. The risk lies in over-dependence on this group, but there is opportunity in pursuing high-value, low-frequency buyers for larger, though less regular, deals. The sales model likely benefits from direct engagement with end-users. Recent updates to Mexico's foreign trade rules, as noted in [International Trade Compliance Update], emphasize the need for compliance in export procedures, reinforcing the importance of staying aligned with regulatory changes for sustained success in Medical Prosthetics exports.

Table: Mexico Medical Prosthetics (HS 9021) Top Buyers List (Source: yTrade)

Buyer CompanyValueQuantityFrequencyWeight
ORMCO CORPORATION301.29K338.608.003.49K
BREG, INC281.88K11.96K615.002.93M
WILSON COOK MEDICAL271.64K94.001.001.28K
GC ORTHODONTICS AMERICA INC************************

Check Full Medical Prosthetics Buyer lists

Action Plan for Medical Prosthetics Market Operation and Expansion

  • Prioritize high-value, high-frequency buyers like BREG, INC to secure stable revenue streams for Mexico's Medical Prosthetics Export, as they drive over 65% of total value according to hs code 9021 trade data.
  • Target the High-Yield Cluster (e.g., Canada, Switzerland) with premium product offerings to capture higher margins, as their value share significantly outpaces quantity share in the Medical Prosthetics supply chain.
  • Diversify the buyer base by pursuing high-value, low-frequency clients for larger, though less regular, orders to mitigate over-dependence on a single buyer segment and boost overall profitability.
  • Optimize logistics for just-in-time delivery to the US, which dominates as the primary destination, to maintain efficiency in the high-volume OEM segment of the Medical Prosthetics supply chain.
  • Continuously monitor regulatory updates and ensure compliance with Mexico's foreign trade rules to avoid disruptions and sustain seamless operations for hs code 9021 trade data-driven exports.

Take Action Now —— Explore Mexico Medical Prosthetics Export Data

Frequently Asked Questions

Q1. What is driving the recent changes in Mexico Medical Prosthetics Export 2025 January?

Mexico's Medical Prosthetics exports reached $450.07 million in January 2025, supported by streamlined customs processes and steady global healthcare demand. The growth reflects Mexico's expanding medical device sector and efficient high-volume production for bulk OEM contracts.

Q2. Who are the main destination countries of Mexico Medical Prosthetics (HS Code 9021) 2025 January?

The United States dominates, absorbing 90.40% of export value. Secondary markets include Canada (2.40%), Switzerland (2.27%), and Ireland (1.86%), which focus on higher-value specialized devices.

Q3. Why does the unit price differ across destination countries of Mexico Medical Prosthetics Export?

Price differences stem from product specialization: orthopaedic appliances (e.g., HS 90211006) average $52/unit, while hearing aids and artificial body parts command $200–$1,100/unit. High-value clusters like Canada prioritize premium finished goods.

Q4. What should exporters in Mexico focus on in the current Medical Prosthetics export market?

Exporters should prioritize relationships with high-value, high-frequency buyers (65.40% of revenue) while targeting niche markets in Canada and Europe for premium margins. Compliance with Mexico’s 2025 trade rules is critical for stability.

Q5. What does this Mexico Medical Prosthetics export pattern mean for buyers in partner countries?

US buyers benefit from integrated, high-volume OEM supply chains, while European and Canadian buyers access specialized devices at higher unit prices. Over-reliance on bulk US shipments may limit diversification opportunities.

Q6. How is Medical Prosthetics typically used in this trade flow?

Exports primarily serve direct manufacturing or medical end-users, with orthopaedic supports ($53/unit) for bulk OEM needs and advanced devices (e.g., hearing aids) for clinical or specialized applications.

Copyright © 2026. All rights reserved.